Showing results (81-90 of 1,278) with videos related to
Sort By:
Pageof 128
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 20, 2017
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple SclerosisHarold L Atkins, Mark S FreedmanSeminars in Oncology|June 1, 1987
Cell surface markers in hematologic malignanciesA S Freedman, L M NadlerSeminars in Hematology|April 3, 2008
Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphomaAnn S LaCasce, Arnold S FreedmanCurrent Opinion in Oncology|July 24, 2012
Early stage follicular lymphoma, current management and controversiesCaron A Jacobson, Arnold S FreedmanMultiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2008
Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon beta-1a: analysis of the PRISMS studyM S Freedman, F G ForrestalAnnals of Hematology|July 3, 1999
High-dose therapy and stem cell transplantation in follicular lymphomaJ W Friedberg, A S FreedmanMedicine, Science, and the Law|April 1, 1996
Cognitive-behavioural treatment of shoplifting in a depressed femaleS Freedman, M Marks, T DalgleishJournal of Neuroimmunology|June 12, 2003
Study of Herpesvirus saimiri immortalization of gammadelta T cells derived from peripheral blood and CSF of multiple sclerosis patientsRobert A Pon, Mark S FreedmanCurrent Treatment Options in Oncology|August 19, 2006
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphomaJonathan W Friedberg, Arnold S FreedmanPageof 128